Found 108 matching trials
ORIENT-31 Regimen in Combination With SBRT for EGFR-mutant Metastatic NSCLC After First-line Third-generation EGFR-TKIs
PHASE2The goal of this prospective study is to explore the safety and preliminary...
Location
Fudan University Shanghai Cancer Center
Bintrafusp Alfa With Chemotherapy for Tyrosine Kinase Inhibitor-Resistant EGFR-Mutant Non-small Cell Lung Cancer
PHASE2This phase II trial studies the effect of bintrafusp alfa with pemetrexed a...
Location
M D Anderson Cancer Center
A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors
PHASE1This is an open-label, two-arm, Phase I, dose escalation study to evaluate ...
Location
GSK Investigational Site
Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutations
PHASE1BDTX-1535-101 is an open-label, Phase 1 dose escalation and Phase 2 multipl...
Status
Active Not Recruiting
Location
University of Alabama
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
PHASE1The purpose of this randomized study is to determine the safety and efficac...
Location
Valkyrie Clinical Trials
Continuation of TKI With or Without Chemotherapy Beyond Gradual Progression
PHASE2There have been reports suggesting that continuous administration of epider...
CIML NK Cell in Head & Neck Cancer
PHASE1This research study is evaluating the safety and efficacy of a combination ...
Location
Dana Farber Cancer Institute
BRIDGE Study: Neoadjuvant Finotonlimab, Cetuximab, and Docetaxel in Resectable Recurrent HNSCC After Immunotherapy Progression
PHASE2This is a multicenter, single-arm, phase II clinical study evaluating the e...
Status
Enrolling By Invitation
Location
The First People's Hospital of Foshan
A Phase II Study of AK146D1 in Combination With AK112 in Advanced Non-Small Cell Lung Cancer
PHASE2This is a phase II clinical study evaluating the safety, tolerability, phar...
Location
SunYat-sen University Cancer Center
Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer
PHASE1RATIONALE: Drugs used in chemotherapy, such as paclitaxel albumin-stabilize...
Location
Baylor Research Institute